CPIC (Clinical Pharmacogenetics Implementation Consortium) is leading an effort to standardize terms for clinical pharmacogenetic tests. The goal of the project is to create standardized terms to be used in CPIC guidelines (specifically Tables 1 and 2) and in the larger pharmacogenetics community. A list of phenotype term options based on an extensive literature review and scanning of sample laboratory reports is being developed. Refinement of the terms will be performed using a modified Delphi method in the context of expert opinions.
CPIC is actively engaging different constituencies including members of the PGRN, ClinGen, the CDC PGx nomenclature working group, clinical laboratories and the IOM PGx roundtable. Further details about this project are described here. If you have questions or comments regarding this project, and/or if you are interested in participating in this process, please contact us at